24/09/2026
6th National Pharmacovigilance Week 2026 – Promoting Safer Healthcare
The Adverse Drug Reaction Monitoring Centre (AMC), Justice K. S. Hegde Charitable Hospital, Department of Pharmacology, K. S. Hegde Medical Academy (KSHEMA), and NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Nitte (Deemed to be University), Mangaluru, successfully conducted the 6th National Pharmacovigilance Week 2026 from 17th to 23rd September 2026.
The week-long observance was organized around the theme:
“Promoting Rational Use of Medicines Through Pharmacovigilance: A Step Towards Safer Healthcare.”
A range of academic, awareness, and community-oriented activities were conducted throughout the week, including an inaugural programme, awareness skit, poster display, community outreach programmes, an elocution competition, a guest lecture, and a valedictory programme.
The community outreach initiatives at Nitte Community Health Centre, pharmacies in Deralakatte, and Ira Rural Community Health Centre provided opportunities to engage with the community and pharmacy professionals on safe medication practices, adverse drug reactions, rational use of medicines, and the importance of reporting suspected adverse drug reactions.
The Guest Lecture on “Promoting Rational Use of Medicines Through Pharmacovigilance: A Step Towards Safer Healthcare” was delivered by Prof. (Dr.) Roopa P. Nayak, Coordinator, AMC, Yenepoya Medical College, Mangaluru, providing valuable insights into pharmacovigilance and medication safety.
The week concluded with a Valedictory Programme and Prize Distribution Ceremony, recognizing the achievements and active participation of students in the Poster Making and Elocution Competitions.
We sincerely appreciate the contributions of the faculty members, students, healthcare professionals, pharmacy professionals, community members, organizers, and participants who contributed to the successful conduct of the 6th National Pharmacovigilance Week.
The programme reinforced an important message: promoting rational use of medicines and strengthening pharmacovigilance are collective responsibilities essential for safer and better healthcare.